{
  "trial_id": "NCT01715129",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, ECOG performance status, baseline testosterone level, life expectancy, prior hormonal therapy, prior surgery or radiotherapy, presence of other malignancies, presence of painful bone or spinal lesions, history of cardiovascular events, presence of other medical or psychiatric conditions, baseline haemoglobin level, absolute neutrophil count, platelet count, serum creatinine level, aspartate aminotransferase level, alanine aminotransferase level, known hypersensitivity to study treatment, recreational drug or alcohol use, use of medications affecting androgenic hormones, use of systemic corticosteroids, participation in other studies, presence of skin conditions, presence of brain or epidural metastases.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex/Gender",
          "sex"
        ],
        [
          "Prostate Specific Antigen (PSA)",
          "baseline testosterone level"
        ]
      ],
      "remaining_reference_features": [
        "Race/Ethnicity",
        "Height",
        "Weight",
        "Body Mass Index (BMI)"
      ],
      "remaining_candidate_features": [
        "ECOG performance status",
        "life expectancy",
        "prior hormonal therapy",
        "prior surgery or radiotherapy",
        "presence of other malignancies",
        "presence of painful bone or spinal lesions",
        "history of cardiovascular events",
        "presence of other medical or psychiatric conditions",
        "baseline haemoglobin level",
        "absolute neutrophil count",
        "platelet count",
        "serum creatinine level",
        "aspartate aminotransferase level",
        "alanine aminotransferase level",
        "known hypersensitivity to study treatment",
        "recreational drug or alcohol use",
        "use of medications affecting androgenic hormones",
        "use of systemic corticosteroids",
        "participation in other studies",
        "presence of skin conditions",
        "presence of brain or epidural metastases"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Race/Ethnicity, Customized, Region of Enrollment, ECOG performance status, Baseline testosterone level, Prostate-specific antigen (PSA) level, Hemoglobin, Absolute neutrophil count, Platelet count, Serum creatinine, Aspartate aminotransferase (AST), Alanine aminotransferase (ALT), ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Prostate Specific Antigen (PSA)",
          "Prostate-specific antigen (PSA) level"
        ]
      ],
      "remaining_reference_features": [
        "Sex/Gender",
        "Height",
        "Weight",
        "Body Mass Index (BMI)"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "ECOG performance status",
        "Baseline testosterone level",
        "Hemoglobin",
        "Absolute neutrophil count",
        "Platelet count",
        "Serum creatinine",
        "Aspartate aminotransferase (AST)",
        "Alanine aminotransferase (ALT)"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Male, Race/Ethnicity Not Collected, Region of Enrollment, ECOG Performance Status, Screening Testosterone Level, Prostate Specific Antigen (PSA) Concentration, Life Expectancy, History of Myocardial Infarction, History of Percutaneous Coronary Intervention, History of Acute Coronary Syndrome, History of Coronary Artery Bypass Graft, History of Class III/IV Congestive Heart Failure, History of Cerebrovascular Accident, History of Transient Ischaemic Attack, History of Limb Claudication at Rest.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex/Gender",
          "Sex: Male"
        ],
        [
          "Prostate Specific Antigen (PSA)",
          "Prostate Specific Antigen (PSA) Concentration"
        ]
      ],
      "remaining_reference_features": [
        "Race/Ethnicity",
        "Height",
        "Weight",
        "Body Mass Index (BMI)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity Not Collected",
        "Region of Enrollment",
        "ECOG Performance Status",
        "Screening Testosterone Level",
        "Life Expectancy",
        "History of Myocardial Infarction",
        "History of Percutaneous Coronary Intervention",
        "History of Acute Coronary Syndrome",
        "History of Coronary Artery Bypass Graft",
        "History of Class III/IV Congestive Heart Failure",
        "History of Cerebrovascular Accident",
        "History of Transient Ischaemic Attack",
        "History of Limb Claudication at Rest."
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, race, ethnicity, weight, height, body mass index (BMI), ECOG performance status, prostate specific antigen (PSA) level, testosterone level, life expectancy, presence of metastases, prior treatments for prostate cancer, medical history (including myocardial infarction, percutaneous coronary intervention, acute coronary syndrome, coronary artery bypass graft, Class III/IV congestive heart failure, cerebrovascular accident, transient ischaemic attack, or limb claudication), concomitant medications, haemoglobin level, absolute neutrophil count, platelet count, serum creatinine level, aspartate aminotransferase level, alanine aminotransferase level.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex/Gender",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "ethnicity"
        ],
        [
          "Height",
          "height"
        ],
        [
          "Weight",
          "weight"
        ],
        [
          "Body Mass Index (BMI)",
          "body mass index (BMI)"
        ],
        [
          "Prostate Specific Antigen (PSA)",
          "prostate specific antigen (PSA) level"
        ]
      ],
      "remaining_reference_features": [],
      "remaining_candidate_features": [
        "ECOG performance status",
        "testosterone level",
        "life expectancy",
        "presence of metastases",
        "prior treatments for prostate cancer",
        "medical history (including myocardial infarction, percutaneous coronary intervention, acute coronary syndrome, coronary artery bypass graft, Class III/IV congestive heart failure, cerebrovascular accident, transient ischaemic attack, or limb claudication)",
        "concomitant medications",
        "haemoglobin level",
        "absolute neutrophil count",
        "platelet count",
        "serum creatinine level",
        "aspartate aminotransferase level",
        "alanine aminotransferase level"
      ]
    }
  }
}